An emulation trial shows that Humira biosimilars (Amjevita & Imraldi) were equivalent to Humira in psoriasis & achieving PASI <=2, both for new biologic starts and for biologic switchers. https://t.co/8lTGGs2rbP https://t.co/T6rTJ5ESj2
Links:
Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
https://buff.ly/i5LUO6d
Apr-23-2025
